AI/ML Efforts, Quick Approvals, Regulator Digitalization: What India Is Doing For Drug Discovery

‘Make In India’ Mantra

AI initiatives in a country known for its software prowess, along with startup support, clinical trial rule changes, crunched approval timelines, unified digital regulatory interfaces and a R&D policy laying out $600m in funds, are all meant to build something greater than the sum of its parts. In a bottom-up approach, India is building an innovation ecosystem

Digital Lightbulb
India's Research Landscape Is Changing • Source: Shutterstock

India is gradually building an innovation ecosystem with an eye on self-reliance.

AI-led initiatives, startup support, a crunch in timelines for regulatory approvals of innovative products by at least 50% in two...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Pink Sheet